{Reference Type}: Journal Article
{Title}: Non-invasive urine-based ELISA using a recombinant Leishmania protein to diagnose tegumentary leishmaniasis.
{Author}: Câmara RSB;Pereira IAG;Lage DP;Vale DL;Ludolf F;Cardoso MM;Freitas CS;Oliveira-da-Silva JA;Assis BPN;Chaves AT;Pimenta BL;Silva MGP;Tavares GSV;Galdino AS;Tupinambás U;Chávez-Fumagalli MA;Pascoal VPM;Eller MTC;Rocha MODC;Machado-de-Ávila RA;Gonçalves DU;Coelho EAF;
{Journal}: Acta Trop
{Volume}: 258
{Issue}: 0
{Year}: 2024 Oct 17
{Factor}: 3.222
{DOI}: 10.1016/j.actatropica.2024.107326
{Abstract}: The diagnosis of tegumentary leishmaniasis (TL) is hampered by variable sensitivity and/or specificity of the tests. Serological assays are suitable to diagnose visceral leishmaniasis (VL); however, they present low performance for the detection of TL cases. Additionally, blood collection to obtain patient serum represents a challenge, as it is an invasive and uncomfortable procedure, requiring laboratorial infrastructure and trained professionals. In this context, the present study proposed to evaluate patient urine to detect TL, given that this analyte has proven to be effective in ELISA experiments for the detection of VL cases. For this, a Leishmania protein called LiHyV, two specific B-cell epitopes derived from protein amino acid sequence, and a Leishmania antigenic extract (SLA) were used as antigens. A total of 215 paired urine and serum samples were evaluated, and results showed that, when serum was employed as an analyte, rLiHyV, Peptide1, Peptide2, and SLA presented a sensitivity of 85 %, 29 %, 58 %, and 31 %, respectively, and a specificity of 97.5 %, 98 %, 100 %, and 97.5 %, respectively, in the diagnosis of TL. When urine was used, rLiHyV, Peptide1, Peptide2, and SLA presented a sensitivity of 95 %, 74 %, 67 %, and 52 %, respectively, and a specificity of 100 %, 99 %, 98 %, and 86 %, respectively. In conclusion, preliminary data suggest that urine could be considered as an alternative biological sample for the detection of TL cases.